AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Which Sectors Lead Indices During Earnings Season examines which sectors typically drive index gains or losses, guiding allocation decisions.
26,374 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Palo Alto Networks stock surged as traders rotated into cybersecurity in a market shifting away from legacy software....
Bill Ackman's closed-end fund recently trades at a sizable discount, prompting questions about a Berkshire-style bet....
A new alliance between Shopify and Google AI is reshaping e-commerce search and discovery. This analysis breaks down ...
A fast-growing tech name in the AI space has dazzled investors, but a recent funding move underscored a crucial risk....
Palantir has slipped significantly from its all-time high, prompting questions about a buy-the-dip opportunity. This ...
Artificial intelligence is reshaping capital flows across tech and beyond. This guide identifies three core AI infras...
Tensions in the Middle East have traders eyeing crude prices. This article examines why analysts predict iran conflic...
AI stocks have pulled back, but the fundamental machine beneath the hype is still growing. Learn why forget sell-off:...
Salesforce faces leadership questions as founder Marc Benioff approaches three decades at the helm. The company is st...
A corporate treasury model pivots back to Bitcoin buying after a pause, adopting a clear buy-for-sell rule. This appr...
Brian Niccol's Starbucks just embarked on an ambitious turnaround driven by technology and service upgrades. This art...